OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antibody-drug conjugates: Principles and opportunities
Zhi Xin Phuna, Prashanth Ashok Kumar, Elio Haroun, et al.
Life Sciences (2024) Vol. 347, pp. 122676-122676
Closed Access | Times Cited: 9
Zhi Xin Phuna, Prashanth Ashok Kumar, Elio Haroun, et al.
Life Sciences (2024) Vol. 347, pp. 122676-122676
Closed Access | Times Cited: 9
Showing 9 citing articles:
Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical Therapies
Sahar Balkhi, Giorgia Bilato, Andrea De Lerma Barbaro, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 69-69
Open Access
Sahar Balkhi, Giorgia Bilato, Andrea De Lerma Barbaro, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 69-69
Open Access
Cancer-targeting drug conjugates drives a new era in precise cancer treatment
Jia Deng, Jianbin Shi, Dan Li, et al.
Chinese Chemical Letters (2025), pp. 110960-110960
Closed Access
Jia Deng, Jianbin Shi, Dan Li, et al.
Chinese Chemical Letters (2025), pp. 110960-110960
Closed Access
Uncovering potential targets for antibody-drug conjugates in the treatment of gynecologic malignancies
Yuying Jiang, Yuance Xu, Junqi He, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Yuying Jiang, Yuance Xu, Junqi He, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Antibody conjugates in neuroblastoma: a step forward in precision medicine
Jihane Balla, Carlotta Siddi, María Scherma, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Jihane Balla, Carlotta Siddi, María Scherma, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Single-Domain Antibodies as Antibody–Drug Conjugates: From Promise to Practice—A Systematic Review
Víctor Manuel Medina Pérez, Marta Baselga, Alberto J. Schuhmacher
Cancers (2024) Vol. 16, Iss. 15, pp. 2681-2681
Open Access | Times Cited: 4
Víctor Manuel Medina Pérez, Marta Baselga, Alberto J. Schuhmacher
Cancers (2024) Vol. 16, Iss. 15, pp. 2681-2681
Open Access | Times Cited: 4
PEGylation of Dipeptide Linker Improves Therapeutic Index and Pharmacokinetics of Antibody-Drug Conjugates
Jing Long, Shao Ting, Yongmei Wang, et al.
Bioconjugate Chemistry (2025)
Closed Access
Jing Long, Shao Ting, Yongmei Wang, et al.
Bioconjugate Chemistry (2025)
Closed Access
Antibody-drug conjugates for non-small cell lung cancer: Advantages and challenges in clinical translation
Chenyu Zhao, Ruihan Zhang, Huazhe Yang, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116378-116378
Closed Access | Times Cited: 2
Chenyu Zhao, Ruihan Zhang, Huazhe Yang, et al.
Biochemical Pharmacology (2024) Vol. 226, pp. 116378-116378
Closed Access | Times Cited: 2
Metabolism of new drug modalities research advances – 2023 year in review
Bin Ma, Upendra A. Argikar, Lionel Cheruzel, et al.
Drug Metabolism Reviews (2024), pp. 1-24
Closed Access
Bin Ma, Upendra A. Argikar, Lionel Cheruzel, et al.
Drug Metabolism Reviews (2024), pp. 1-24
Closed Access
Monoclonal Antibody Therapies in Cancer Immunotherapy
Charuwan Thanawiroon, Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 419-472
Closed Access
Charuwan Thanawiroon, Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 419-472
Closed Access
